Medicinal cannabis sales will double in 2021, driven by a rapid growth in patient numbers and Authorised Prescribers (APs), according to the latest report from FreshLeaf Analytics.

Join the Cannabiz revolution

Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?

This article is included with our Premium subscription.

Based on data collected from 45 suppliers and 1,000 CA Clinics patients in January and February 2021, the company’s H1 2021 Patient, Product and Pricing Analysis predicts sales will increase from A$100m to $200m, with active patient numbers up from 30,000 to 75,000 by the end of the year.

Prior to launching Cannabiz, Martin was co-founder and CEO of Asia-Pac’s leading B2B media and marketing information brand Mumbrella, overseeing its sale to Diversified Communications in 2017. A journalist...